Prostate cancer: Developing novel approaches to castration‐sensitive disease

Overview of attention for article published in Cancer (0008543X), November 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy: 1 policy source

twitter: 30 X users

Readers on

mendeley: 48 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Prostate cancer: diagnosis and management : B: Docetaxel in people with hormone-sensitive prostate cancer

Cited by National Institute for Health and Care Excellence (NICE) on 17 Jul 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.